Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C-Reference-Cited by-同舟云学术

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

Published:2014-02-28 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hauser Goran¹²,Awad Tahany²,Brok Jesper³,Thorlund Kristian⁴,Štimac Davor¹,Mabrouk Mahasen⁵,Gluud Christian²,Gluud Lise Lotte⁶

Affiliation:

1. Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51 000

2. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Department 7812, Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark

3. Rigshospitalet; Paediatric Department 4072; Blemdagsvej 9 Copenhagen Denmark 2100 Ø

4. McMaster University; Department of Clinical Epidemiology and Biostatistics; Hamilton Ontario Canada

5. Faculty of Medicine, Cairo University; Endemic Medicine and Liver Department; Cairo Egypt

6. Copenhagen University Hospital Hvidovre; Gastro Unit, Medical Division; Kettegaards Alle Hvidovre Denmark 2650

Publisher

Wiley

Subject

Pharmacology (medical)

Reference147 articles.

1. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4;Alfaleh;Liver International,2004

2. Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial;Bruno;Journal of Hepatology,2004

3. Chronic hepatitis C (CH-C) genotype 1: an independent, multicenter RCT comparing PEG-IFN alfa-2b 12 kD plus ribavirin (RBV) and IFN alfa-2b plus RBV in naive patients;Bruno;Journal of Hepatology,2003

4. PEG-INF alpha-2A (40KD) plus ribavirin (RBV) vs IFN alpha-2A (ROFERON-A) in naive patients with chronic hepatitis C (CHC) and genotype 1 [AASLD abstract];Cariti;Hepatology,2002

5. Pegylated interferon-alpha 2b- ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis;Derbala;Journal of Viral Hepatitis,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Hepatitis C in Children and Adolescents;Journal of the Pediatric Infectious Diseases Society;2020-10-12

2. Reinforced reasoning in medicine;Journal of Evaluation in Clinical Practice;2020-04

3. Outcome of hepatitis C patients in a community with predominant genotype 3 with standard-of-care treatment before and after advent of direct-acting antivirals: A retrospective-cum-prospective study;Indian Journal of Pharmacology;2020

4. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review;Journal of Clinical Laboratory Analysis;2019-03-07

5. Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden;Infectious Diseases;2018-11-30